Global Healthcare Licensing - Regional Trends: USA-to-from-Emerging Markets Mid-Year Review

  • ID: 4604806
  • Report
  • Region: Global
  • 192 pages
  • FinGlobe, Inc
1 of 3
This mid-year review report brings at one place all the news for licensing deals and negotiations that took place between healthcare companies of United States and Emerging Markets during January 1, 2018 to June 30, 2018. The licensing trends and directions during this time period are also analyzed comprehensively.

Key Features:
  • 6 months’ USA-Emerging Markets healthcare licensing news at one place
  • Small, medium and big multinational/non-multinational companies covered
  • Curated categorizations of licensing news
  • 8+ variables reflecting different forms of transactions done
  • Licensing trends and directions summarized
The Report is useful to:
  • United States and Emerging Markets’ healthcare companies planning to introduce products in each other’s markets
  • Companies active in R&D and seeking new market base
  • Healthcare company executives negotiating licensing deals between United States and Emerging Markets’ companies
  • Investors analyzing varied kinds of transaction options for licensing deals
Key analysis provided: January-June 2018
  • Total number of licensing deals from United States to Emerging Markets’ companies
  • Total number of licensing deals from Emerging Markets’ companies to United States
  • Total number of companies/institutes involved in USA-Emerging Markets licensing deals
  • Most licensing deals signed by companies of which sub-industry within healthcare sector
  • Most licensing deals signed by which market capitalization group’s companies
  • Most licensing deals signed by which medicine groups
  • Licensing payment arrangements most followed in the licensing deals between United States and Emerging Markets’ companies
  • Number of domestic and worldwide licensing between United States and Emerging Markets’ companies
  • Number of R&D and commercialization licensing between United States and Emerging Markets’ companies
  • Number of licensing deals discontinued between United States and Emerging Markets’ companies
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Introduction

Research Design

Section 1: Healthcare inventions licensed by United States to Emerging Markets
1.1 By United States company name
1.2 By Emerging Markets company name
1.3 By Sub-industry
1.4 By Market capitalization groups
1.5 By Terms of payment
1.6 By Medical groups

Section 2: Healthcare inventions licensed by Emerging Markets to United States
2.1 By Emerging Markets company name
2.2 By United States company name
2.3 By Sub-industry
2.4 By Market capitalization groups
2.5 By Terms of payment
2.6 By Medical groups

Section 3: Trends in USA-Emerging Markets healthcare licensing deals
3.1 Healthcare sub-sector with most licensing deals
3.2 Market capitalization groups with most licensing deals
3.3 Healthcare companies most active in outbound and inbound licensing deals
3.4 Medical groups most active in licensing deals
3.5 Licensing payment arrangements most followed
3.6 Worldwide licensing vs domestic licensing
3.7 R&D licensing vs commercialization licensing
3.8 Licensing deals which discontinued

Section 4: Trends and directions

Appendices
Appendix 1 List of United States-based companies/institutes covered in this report
Appendix 2 List of Emerging Markets-based companies/institutes covered in this report
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll